GeminIQ Website Logo

Viewing BDPT free

Start free trial

Subscribe for full history, 90+ metrics, screener, watchlist...

BIOADAPTIVES, INC.

BDPT

Companies in Pharmaceutical Preparations

LLYJNJABBVMRKABTPFE

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

Values in Millions ($)
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Assets New
Series C Preferred Stock
-----1---1--
Series D Preferred Stock
-----20---20--
Marketable Securities Current
---------000
Cash And Cash Equivalents At Carrying Value
000000000000
Assets
Accounts Payable Current
----------0-
Accounts Receivable Net
--00--------
Inventory Net
000000000000
Security Deposit
0000000000--
Prepaid Expense Current
0000000000--
Other Receivables
-00000---0--
Assets Current
000000000000
Intangible Assets Net Excluding Goodwill
-0---0------
Property Plant And Equipment Net
0-00--------
Assets
000000000000
Indefinite Lived License Agreements
-----0000000
Liabilities And Stockhold…
Accounts Payable And Accrued Liabilities Current
000000000000
Derivative Liabilities Current
221111111111
Liabilities Current
Liabilities Current
222122222212
Convertible Notes Payable
------0-----
Notes Payable Current
------0-----
Convertible Notes Payable Current
000000-00000
Notes Payable
000000-0-0--
Other Liabilities Current
--0---------
Liabilities
222122222212
Common Stock Value
000000000000
Stockholders Equity
Stockholders Equity
-2-2-1-1-2-1-2-2-2-2-1-2
Additional Paid In Capital
998888777776
Common Stock Share Subscribed But Unissued Subscri…
-0-0-0-0-0-0---0--
Retained Earnings Accumulated Deficit
-11-11-10-10-9-9-9-9-9-8-8-8
Debt Instrument Unamortized Discount
----------00
Liabilities And Stockholders Equity
000000000000
Preferred Stock Par Or Stated Value Per Share
0.0010.0010000000000
Preferred Stock Shares Authorized
313131311031101010101010
Common Stock Par Or Stated Value Per Share
0.00100000000000
Common Stock Shares Authorized
1,2501,2501,2501,2501,2501,2501,2501,2501,2501,2501,2501,250
Common Stock Shares Issued
12121110981,2321,2321,1556776576
Shares Outstanding
12121110981,2321,2321,1556776576
Common Stock Capital Shares Reserved For Future Is…
0000000000--

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
2026-34.64%-87.00%----------
2025-1.69%11.85%-14.59%61.02%18.11%102.17%10.71%-21.43%-42.86%0.00%-34.64%-87.00%
202420.00%-10.00%-20.00%16.67%-16.67%-66.67%66.67%98.50%204.17%-37.91%-38.94%-30.53%
2023---38.89%-33.33%-69.44%-33.33%-55.56%11.11%10.00%20.00%10.00%

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
0.05
0.09
0.07
0.18
0.07
0.15
0.03
0.00
0.02
0.05
0.11
0.03
Quick Ratio
0.03
0.07
0.04
0.15
0.03
0.08
0.03
0.00
0.01
0.04
0.11
0.02
Working Capital
-2.15M
-2.14M
-1.48M
-1.15M
-1.57M
-1.46M
-1.81M
-1.92M
-1.82M
-1.66M
-1.31M
-1.68M
Leverage & Debt
Debt to Equity
-1.06
-1.11
-1.08
-1.24
-1.07
-1.18
-1.03
-1.00
-1.03
-1.06
-1.29
-1.03
Interest Coverage TTM
-6.65
-14.70
-26.22
-25.53
-17.05
-6.55
-2.69
-2.25
-1.56
-1.41
-1.33
-1.96
Debt Ratio
16.71
10.43
12.78
5.17
15.22
6.59
39.91
221.00
31.65
16.83
4.48
35.77
Efficiency & Turnover
Asset Turnover TTM
0.19
0.07
0.09
0.02
0.01
0.07
0.11
1.25
1.04
0.40
0.14
0.22
Per Share Metrics
Diluted EPS TTM
-0.12
-0.15
-0.11
-0.08
-0.09
-0.11
-0.10
-0.26
-0.10
-0.00
-
-0.00
Free Cash Flow Per Share TTM
-0.04
-0.04
-0.04
-0.04
-0.03
-0.03
-0.00
-0.00
-0.00
-0.04
-0.00
-0.00
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Gross Profit Margin TTM
69.81%
-
-
-
-
-
-
32.04%
33.46%
37.88%
36.10%
49.86%
Operating Profit Margin TTM
-4,166.29%
-5,701.79%
-14,410.84%
-30,681.80%
-118,726.81%
-4,752.47%
-1,643.36%
-835.63%
-698.65%
-801.40%
-659.37%
-574.75%
Net Profit Margin TTM
-6,186.31%
-8,523.35%
-14,091.71%
-23,749.21%
-116,976.30%
-7,097.33%
-4,004.40%
-2,170.91%
-1,968.60%
-2,494.19%
-1,863.82%
-5,643.65%
Growth Metrics
Net Revenue Growth (1Y)
3,424.74%
44.27%
-60.49%
-90.94%
-98.18%
-55.65%
-21.61%
172.47%
147.57%
66.31%
48.73%
-31.56%
Net Income Growth (1Y)
86.41%
73.26%
39.04%
-0.86%
7.87%
26.20%
68.42%
4.81%
-10.25%
-20.45%
-56.32%
-12.39%
EPS Growth (1Y)
40.46%
18.53%
11,286.19%
12,174.90%
13,666.08%
-8.26%
37.25%
-50.95%
-70.08%
3,264.50%
-92.05%
-88.23%
Valuation Metrics
P/E TTM
-0.09
-0.17
-0.35
-0.78
-1.14
-0.55
-118.21
-131.79
-141.98
-0.63
-556.26
-129.29
P/B TTM
-0.06
-0.12
-0.26
-0.52
-0.58
-0.34
-52.10
-52.88
-57.81
-0.27
-229.35
-56.67
P/S TTM
5.55
14.52
48.63
185.13
1,339.20
38.91
4,733.51
2,860.94
2,795.08
15.68
10,367.77
7,296.58
Market Cap
132.10K
265.39K
381.76K
595.92K
903.96K
492.93K
94.05M
101.62M
103.93M
447.88K
262.80M
95.12M
Enterprise Value
514.80K
491.38K
713.88K
728.44K
1.21M
912.27K
94.04M
101.96M
104.22M
708.76K
262.98M
95.39M
Calculated Values
Free Cash Flow TTM
-520.96K
-534.03K
-478.74K
-383.77K
-306.24K
-249.52K
-240.28K
-240.08K
-245.49K
-223.77K
-159.98K
-165.37K
Net Debt
382.70K
225.98K
332.12K
132.51K
303.53K
419.35K
-11.80K
342.86K
294.51K
260.88K
173.60K
275.62K
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2024-11-22Purchase
Owner: Dissanayake, Gimhana Sasa…
Title: -
Shares: 125,000
Price/Share: $0.09
Value: $11,250.00
Shares Owned: 125,000
Relationship: Director
Ownership: Direct

Subscribe to unlock 17+ years of data

Start free trial
No institutional ownership data available.

BIOADAPTIVES, INC. (BDPT) — SEC Financial Statements & Analysis

BIOADAPTIVES, INC. (BDPT) is a pharmaceutical preparations company, incorporated in DE. BIOADAPTIVES, INC. trades on OTC as: BDPT. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), BIOADAPTIVES, INC. reported a 3424.74% year-over-year revenue growth, a Gross Profit Margin of 69.81% (TTM), a Debt-to-Equity ratio of -1.06x, a Price-to-Sales (P/S) ratio of 5.55x (TTM), a Price-to-Book (P/B) ratio of -0.06 (TTM), at a market cap of $132.10K. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
3424.74%
Gross Profit Margin TTM
69.81%
Debt To Equity
-1.06x
P/S TTM
5.55x
P/B TTM
-0.06
Market Cap
$132.10K

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is BIOADAPTIVES, INC. in?

BIOADAPTIVES, INC. (BDPT) operates in the Pharmaceutical Preparations industry.

What is BDPT's market cap?

BIOADAPTIVES, INC. (BDPT) has a market capitalization of $132.10K as of 2026-03-31.

What exchange does BDPT trade on?

BIOADAPTIVES, INC. (BDPT) trades on the OTC.

Where is BIOADAPTIVES, INC. incorporated?

BIOADAPTIVES, INC. is incorporated in DE.

Research Faster.
Invest Smarter.

Start 7-day free trial

BIOADAPTIVES, INC. (BDPT) financial data sourced directly from SEC EDGAR filings — including the latest 10-K annual report, 10-Q quarterly filings, insider transactions (SEC Form 4), institutional ownership (SEC Form 13F), Earning Marker Reaction Heat Map and 90+ calculated financial metrics like Price to Earnings Ratio (P/E), Return on Equity (ROE), Debt to Equity (D/E), Free Cash Flow Per Share (FCF/S), and Return on Invested Capital (ROIC). Unlike platforms that rely on third-party data aggregators, GeminIQ parses raw SEC filings directly — delivering institutional-grade accuracy at a fraction of the cost of Bloomberg Terminal or S&P Capital IQ.